Background: Myasthenia Gravis (MG) is a chronic autoimmune neuromuscular disease characterized
by skeletal muscle weakness which improves after rest. MG is caused by a defect in
the neuromuscular transmission caused by antibodies which block, attenuate, or destroy
acetylcholine receptors preventing muscle contraction.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to CytotherapyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
